Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors — Stella
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(1 site)
Hong Kong
Endoscopy Centre, Prince of Wales Hospital, Hong Kong, N.T.